Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium

Author： Hainsworth John D.   Waterhouse David M.   Penley William C.   Shipley Dianna L.   Thompson Dana S.   Webb Charles D.   Anthony Greco F.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.31, Iss.5, 2013-06, pp. : 323-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

By Koh Y.   Lim H. Y.   Ahn J. H.   Lee J.-L.   Rha S. Y.   Kim Y. J.   Kim T. M.   Lee S.-H.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1026-1031

Oxford University Press

Access to resources Recommend Favorite

A multicenter, phase II study of the RAF-kinase inhibitor sorafenib in patients with advanced renal cell carcinoma

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1099-1102

Science Publishers

Access to resources Recommend Favorite

Cisplatin and Pentoxifylline in Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

By Mannel R.S.   Blessing J.A.   Boike G.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 64-66

Elsevier

Access to resources Recommend Favorite

Phase I-II Trial of Preoperative Chemoradiation in Locally Advanced Cervical Carcinoma

By Mancuso S.   Smaniotto D.   Benedetti Panici P.   Favale B.   Greggi S.   Manfredi R.   Margariti P.A.   Morganti A.G.   Scambia G.   Tortoreto F.   Valentini V.   Cellini N.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 324-328

Elsevier

Access to resources Recommend Favorite

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

By Bruce Justine   Kolesar Jill   Hammers Hans   Stein Mark   Carmichael Lakeesha   Eickhoff Jens   Johnston Susan   Binger Kimberly   Heideman Jennifer   Perlman Scott   Jeraj Robert   Liu Glenn  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 485-493

Springer Publishing Company

Access to resources Recommend Favorite